iNtRON Biotechnology Inc

048530

Company Profile

  • Business description

    iNtRON Biotechnology Inc is a Korea-based biotechnology firm focused on the research, development, and commercialization of biopharmaceuticals and molecular diagnostics. Its core business includes developing bacteriophage- and endolysin-based therapeutic platforms for infectious diseases, immune disorders, microbiome-related diseases, vaccines, and oncology applications. It also develops and manufactures PCR/qPCR-based molecular diagnostic kits for human and animal infectious diseases, supported by GMP-certified automated production facilities. In addition, the company pursues strategic partnerships and equity investments to expand its biotechnology ecosystem and commercialize technologies derived from its drug development programs.

  • Contact

    137 Sagimakgol-ro
    701-704, Jungang Induspia 5
    Jungwon-gu
    Gyeonggi-do
    Seongnam-si
    KOR

    T: +82 317395678

    http://www.intron.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    73

Stocks News & Analysis

stocks

SK Hynix Earnings: We raise fair value estimate on strong AI memory demand

Shares jumped 9% after earnings, as stronger AI memory prices boosted the chipmaker’s outlook.
stocks

Meta shares are down 12% since earnings. Is the stock a buy?

Concerns about equity sales to finance AI investments have pressured shares.
stocks

SpaceX earnings: We raise our fair value estimate on scaling data centres, but is the stock a buy?

AI data center revenue is growing fast, but questions about durability remain.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,012.6041.200.46%
CAC 407,970.0083.041.05%
DAX 4026,039.68335.661.31%
Dow JONES (US)52,342.62132.48-0.25%
FTSE 10010,722.0727.570.26%
HKSE22,958.65136.18-0.59%
NASDAQ26,184.72365.13-1.38%
Nikkei 22564,659.47705.281.10%
NZX 50 Index13,710.1718.840.14%
S&P 5007,720.2223.76-0.31%
S&P/ASX 2008,891.8044.500.50%
SSE Composite Index3,651.4330.04-0.82%

Market Movers